Phreesia Inc is a healthcare technology company that focuses on transforming the patient experience
It provides a software platform designed to streamline patient intake processes, enhance communication between patients and healthcare providers, and improve overall administrative efficiency within medical practices. By offering solutions such as patient surveys, appointment scheduling, and payment processing, Phreesia aims to optimize workflows, increase patient engagement, and ultimately contribute to better health outcomes. The company is committed to empowering both patients and providers through innovative technology that enhances the healthcare journey.
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the healthcare technology for providers stocks, including Phreesia (NYSEPHR) and its peers.
Healthcare technology company Phreesia (NYSEPHR) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 15.4% year on year to $109.7 million. The company expects the full year’s revenue to be around $477 million, close to analysts’ estimates. Its GAAP loss of $0.11 per share was 35% above analysts’ consensus estimates.
